-
Something wrong with this record ?
Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells
E. Javorkova, P. Trosan, A. Zajicova, M. Krulova, M. Hajkova, V. Holan,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24849741
DOI
10.1089/scd.2013.0568
Knihovny.cz E-resources
- MeSH
- Alkalies toxicity MeSH
- Allografts MeSH
- Antiviral Agents pharmacology MeSH
- Burns, Chemical pathology therapy MeSH
- Interferon-gamma pharmacology MeSH
- Interleukin-1alpha metabolism MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Stem Cell Niche * MeSH
- Eye Burns chemically induced metabolism pathology therapy MeSH
- Transforming Growth Factor beta metabolism MeSH
- Mesenchymal Stem Cell Transplantation * MeSH
- Inflammation chemically induced metabolism therapy MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The aim of this study was to investigate the effects of systemically administered bone-marrow-derived mesenchymal stromal cells (MSCs) on the early acute phase of inflammation in the alkali-burned eye. Mice with damaged eyes were either untreated or treated 24 h after the injury with an intravenous administration of fluorescent-dye-labeled MSCs that were unstimulated or pretreated with interleukin-1α (IL-1α), transforming growth factor-β (TGF-β), or interferon-γ (IFN-γ). Analysis of cell suspensions prepared from the eyes of treated mice on day 3 after the alkali burn revealed that MSCs specifically migrated to the damaged eye and that the number of labeled MSCs was more than 30-times higher in damaged eyes compared with control eyes. The study of the composition of the leukocyte populations within the damaged eyes showed that all types of tested MSCs slightly decreased the number of infiltrating lymphoid and myeloid cells, but only MSCs pretreated with IFN-γ significantly decreased the percentage of eye-infiltrating cells with a more profound effect on myeloid cells. Determining cytokine and NO production in the damaged eyes confirmed that the most effective immunomodulation was achieved with MSCs pretreated with IFN-γ, which significantly decreased the levels of the proinflammatory molecules IL-1α, IL-6, and NO. Taken together, the results show that systemically administered MSCs specifically migrate to the damaged eye and that IFN-γ-pretreated MSCs are superior in inhibiting the acute phase of inflammation, decreasing leukocyte infiltration, and attenuating the early inflammatory environment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023394
- 003
- CZ-PrNML
- 005
- 20150727103838.0
- 007
- ta
- 008
- 150709s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/scd.2013.0568 $2 doi
- 035 __
- $a (PubMed)24849741
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Javorkova, Eliska $u 1 Institute of Experimental Medicine, Academy of Sciences of the Czech Republic , Prague, Czech Republic .
- 245 10
- $a Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells / $c E. Javorkova, P. Trosan, A. Zajicova, M. Krulova, M. Hajkova, V. Holan,
- 520 9_
- $a The aim of this study was to investigate the effects of systemically administered bone-marrow-derived mesenchymal stromal cells (MSCs) on the early acute phase of inflammation in the alkali-burned eye. Mice with damaged eyes were either untreated or treated 24 h after the injury with an intravenous administration of fluorescent-dye-labeled MSCs that were unstimulated or pretreated with interleukin-1α (IL-1α), transforming growth factor-β (TGF-β), or interferon-γ (IFN-γ). Analysis of cell suspensions prepared from the eyes of treated mice on day 3 after the alkali burn revealed that MSCs specifically migrated to the damaged eye and that the number of labeled MSCs was more than 30-times higher in damaged eyes compared with control eyes. The study of the composition of the leukocyte populations within the damaged eyes showed that all types of tested MSCs slightly decreased the number of infiltrating lymphoid and myeloid cells, but only MSCs pretreated with IFN-γ significantly decreased the percentage of eye-infiltrating cells with a more profound effect on myeloid cells. Determining cytokine and NO production in the damaged eyes confirmed that the most effective immunomodulation was achieved with MSCs pretreated with IFN-γ, which significantly decreased the levels of the proinflammatory molecules IL-1α, IL-6, and NO. Taken together, the results show that systemically administered MSCs specifically migrate to the damaged eye and that IFN-γ-pretreated MSCs are superior in inhibiting the acute phase of inflammation, decreasing leukocyte infiltration, and attenuating the early inflammatory environment.
- 650 _2
- $a alkálie $x toxicita $7 D000468
- 650 _2
- $a alografty $7 D064591
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antivirové látky $x farmakologie $7 D000998
- 650 _2
- $a chemické popálení $x patologie $x terapie $7 D002057
- 650 _2
- $a popálení oka $x chemicky indukované $x metabolismus $x patologie $x terapie $7 D005126
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zánět $x chemicky indukované $x metabolismus $x terapie $7 D007249
- 650 _2
- $a interferon gama $x farmakologie $7 D007371
- 650 _2
- $a interleukin-1alfa $x metabolismus $7 D053582
- 650 12
- $a transplantace mezenchymálních kmenových buněk $7 D045164
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 12
- $a nika kmenových buněk $7 D055153
- 650 _2
- $a transformující růstový faktor beta $x metabolismus $7 D016212
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Trosan, Peter
- 700 1_
- $a Zajicova, Alena
- 700 1_
- $a Krulova, Magdalena
- 700 1_
- $a Hajkova, Michaela
- 700 1_
- $a Holan, Vladimir
- 773 0_
- $w MED00162608 $t Stem cells and development $x 1557-8534 $g Roč. 23, č. 20 (2014), s. 2490-500
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24849741 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150727103921 $b ABA008
- 999 __
- $a ok $b bmc $g 1083731 $s 906387
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 23 $c 20 $d 2490-500 $i 1557-8534 $m Stem cells and development $n Stem Cells Dev $x MED00162608
- LZP __
- $a Pubmed-20150709